The researchers created a tool to predict which patients will respond to this therapy based on this therapy that shows the importance of metabolism in the tumor microenvironment.
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
JPOST Digital Library
